Evidence map›Paper›PMID 35456796›Full record

ReviewMicroorganisms2022

The Effects of Stevia Consumption on Gut Bacteria: Friend or Foe?

Arezina N Kasti, Maroulla D Nikolaki, Kalliopi D Synodinou, Konstantinos N Katsas, Konstantinos Petsis, Sophia Lambrinou, Ioannis A Pyrousis, Konstantinos Triantafyllou

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Steviol Glycosides (E960) FromFood science & nutrition · 2026
    Review
  3. Article
  4. The progress on stevia (Frontiers in nutrition · 2026
    Review
  5. Review
  6. Article
  7. Stevia Leaf Extract Fermented with Plant-DerivedInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Seeds ofInternational journal of molecular sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Arezina N KastiDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.ORCID 0000-0001-7282-4939
Maroulla D NikolakiDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.ORCID 0000-0002-0546-722X
Kalliopi D SynodinouDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.
Konstantinos N KatsasDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.ORCID 0000-0002-3327-9330
Konstantinos PetsisDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.ORCID 0000-0003-3632-2127
Sophia LambrinouDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.ORCID 0000-0003-2475-3472
Ioannis A PyrousisDepartment of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.
Konstantinos TriantafyllouHepatogastroenterology Unit, 2nd Department of Propaedeutic Internal Medicine, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.ORCID 0000-0002-5183-9426
University General Hospital Attikon · GRNational and Kapodistrian University of Athens · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stevia, a zero-calorie sugar substitute, is recognized as safe by the Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). In vitro and in vivo studies showed that stevia has antiglycemic action and antioxidant effects in adipose tissue and the vascular wall, reduces blood pressure levels and hepatic steatosis, stabilizes the atherosclerotic plaque, and ameliorates liver and kidney damage. The metabolism of steviol glycosides is dependent upon gut microbiota, which breaks down glycosides into steviol that can be absorbed by the host. In this review, we elucidated the effects of stevia's consumption on the host's gut microbiota. Due to the lack of randomized clinical trials in humans, we included in vitro using certain microbial strains and in vivo in laboratory animal studies. Results indicated that stevia consumption has a potential benefit on the microbiome's alpha diversity. Alterations in the colonic microenvironment may depend on the amount and frequency of stevia intake, as well as on the simultaneous consumption of other dietary components. The anti-inflammatory properties of stevioside were confirmed in vitro by decreasing TNF-α, IL-1β, IL-6 synthesis and inhibiting of NF-κB transcription factor, and in vivo by inhibiting NF-κB and MAPK in laboratory animals.

Indexed as

bacteriafecal floragut microbiotaStevia rebaudianastevioside

Identifiers

PMID35456796
PMCPMC9028423
OpenAlexW4221056484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.